AI Summary
Summary: This clinical trial compares the safety and effectiveness of MW032 to denosumab in patients with solid tumor-related bone metastases. The goal is to determine if MW032 is a viable alternative treatment option.
This clinical trial examines the safety, efficacy, and biosimilarity of MW032 compared with denosumab in patients with solid tumor–related bone metastases.